REMOTE ISCHEMIC PRECONDITIONING TO REDUCE CONTRAST-INDUCED NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS
|
|
- Matthew Price
- 5 years ago
- Views:
Transcription
1 REMOTE ISCHEMIC PRECONDITIONING TO REDUCE CONTRAST-INDUCED NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS AUTHORS 1. T.B.R.M. Sterenborg 2. M. Ergün 3. T.P. Menting 4. J.F. Wetzels 5. L.J. SchultzeKool 6. M.M. Rovers 7. M.C. Warlé Nijmegen, the Netherlands March, 2016
2 TITLE PAGE Remote ischemic preconditioning to reduce contrast induced nephropathy: a systematic review and meta-analysis AUTHORS 1. T.B.R.M. Sterenborg 1 2. M. Ergün 1 3. T.P. Menting 1 4. J.F. Wetzels 2 5. L.J. SchultzeKool 3 6. M.M. Rovers 4 7. M.C. Warlé 1 INSTITUTES 1. Department of Surgery, division of Vascular- and Transplant Surgery, Radboudumc, Nijmegen, the Netherlands 2. Department of Nephrology, Radboudumc, Nijmegen, the Netherlands 3. Department of Radiology, Radboudumc, Nijmegen, the Netherlands 4. Department of Health Evidence, Radboudumc, Nijmegen, the Netherlands CORRESPONDENCE T.B.R.M. Sterenborg, BSc Department of Surgery, division of Vascular and Transplant Surgery, RadboudUMC Geert Grooteplein-Zuid GA, Nijmegen, the Netherlands Thomas.Sterenborg@radboudumc.nl KEYWORDS Remote ischemic preconditioning, contrast media, contrast-induced nephropathy, acute kidney injury, humans, randomized controlled trial, meta-analysis, review 2
3 INTRODUCTION Contrast media used for diagnostic and therapeutic procedures is the leading cause of hospitalacquired acute kidney injury (1). The incidence of contrast-induced acute kidney injury (CI-AKI) is still significant despite the increasing use of low-osmolar instead of high-osmolar iodine-containing contrast media and hydration protocols (2, 3). This so called contrast-induced nephropathy (CIN) is defined as an absolute rise of 0.5 mg/dl and/or a relative increase of 25% in serum creatinine compared to baseline within 48 to 72 hours after contrast administration without an alternative cause of kidney injury (4). In patients with CIN, % requires dialysis treatment and % had an one-year mortality (5). Contrast media are used in cardiac and vascular interventions and radiological diagnostics. The pathogenesis of CIN is complex and not fully understood. Contrast media may have direct toxic effects on tubular cells but may also cause vasoconstriction of the vasa recta leading to tubular ischemia. Increased viscosity may also contribute to decreased oxygen delivery of the vasa recta (6). The episode of tubular cell ischemia is followed by reperfusion which may cause ischemiareperfusion injury of the kidney after contrast administration. Remote ischemic preconditioning (RIPC) is a short and harmless discontinuation of blood supply to an organ or tissue, followed by reperfusion that is applied before the onset of prolonged ischemia to a distant organ or tissue (7, 8). Although the precise mechanism of RIPC remains unknown, two major pathways may play a role: the humoral and neurogenic pathways (9). The protective effects of RIPC on renal ischemia-reperfusion injury has been shown in many animal studies (10, 11). Human trials also indicate that remote ischemic preconditioning may offer a novel, nonpharmacological prevention strategy to reduce CI-AKI (12, 13). To determine whether evidence to date supports the use of RIPC, as a non-invasive, safe, and lowcost method, to reduce contrast mediated kidney injury, a systematic review with meta-analysis is required. OBJECTIVE A systematic review with separate meta-analyses for randomized controlled clinical trials following The Cochrane Collaboration methodology will be conducted (14). The main objective is to evaluate the effect of RIPC in the prevention of contrast-induced nephropathy in patients with preexisting kidney disease who undergo a diagnostic or therapeutic intervention for which intravascular contrast is used. 3
4 METHODS CRITERIA FOR CONSIDERING TRIALS FOR THIS SYSTEMATIC REVIEW STUDIES All randomized controlled clinical trials irrespective of language, blinding or publication status will be considered for inclusion. Inclusion criteria: All studies evaluating the effect of remote ischemic preconditioning in patients at risk of contrastinduced AKI. PATIENTS All adult patients ( 18 years) in high risk for CIN defined as egfr <60 ml/min/1.73m² with or without additional risk factors, who undergo a diagnostic or therapeutic intervention with the use of contrast media. Risk factors are listed in table 1 (2, 5, 15, 16). EXPERIMENTAL INTERVENTION Patients in the experimental group of the study will receive intermittent RIPC of ischemia and reperfusion by inflating a blood pressure cuff around the upper extremity, the lower extremity or both. CONTROL INTERVENTION Patients in the control group receive sham preconditioning or no preconditioning. OUTCOMES Primary outcome: Incidence of contrast-induced nephropathy (absolute rise of 0.5 mg/dl and/or a relative increase of 25% in serum creatinine compared to baseline within 48 to 72 hours after contrast administration) Secondary outcomes: Change in serum creatinine from baseline to day 2-3 after contrast administration. Other biomarkers (e.g. Cystatin C, NGAL, KIM-1, L-FABP) (17) Mortality during index hospitalization or within 30 days Dialysis during index hospitalization or within 30 days 4
5 Rehospitalization during index hospitalization or within 30 days SEARCH METHODS FOR IDENTIFICATIONS OF STUDIES The Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library, PubMed/MEDLINE, EMBASE and Web of Science will be searched. The references of the identified trials and cross references will be searched to identify any further relevant randomized clinical trials. All randomized controlled clinical trials irrespective of language, blinding or publication status will be considered for inclusion. TRIAL REGISTRIES TRIAL SELECTION AND EXTRACTION OF DATA Two authors (TS and ME) will independently identify trials and studies for inclusion. The authors will make a list of excluded studies with reasons for exclusion. The authors will extract: year and language of publication year of conduction of the trial patient demographics (e.g. number of patients, mean age, gender, medication used, risk factors for CIN, MDRD in ml/min) standard preventive measures (e.g. hydration protocol, discount of medication) RIPC protocol (number of inflations, extremity used for preconditioning) amount of contrast media administered outcome measures (see OUTCOMES, page 4/5.) The PRISMA checklist and PRISMA flow diagram for systematic reviews will be used (18). In case of discrepancies, consensus will be reached by discussion or consultation of an independent researcher (MW). If there is unclear or missing data the corresponding authors of the individual trials will be contacted. ASSESSMENT OF BIAS RISK The two authors (TS and ME) will assess the risk of bias, without masking for trial names, according to the Cochrane Handbook for Systematic Reviews of Interventions (14). Sequence generation low risk of bias (a random component in sequence generation process is described) 5
6 uncertain risk of bias (insufficient information to assess whether the method used is likely to introduce confounders) high risk of bias (the method is improper and likely of introduce confounding, e.g. performed by date of admission) Allocation concealment low risk of bias (if the unit of allocation was by institution, team or professional; allocation was performed on all units at the start of the study and there was some form of centralized randomization) uncertain risk of bias (insufficient information to assess whether the method used is likely to induce bias on the estimate of effect) high risk of bias (the method used is likely to induce bias on the final observed effect) Blinding of participants, personnel (e.g. surgeon, radiologist) and outcome assessors low risk of bias (blinding was performed adequately or outcome measurement is not likely to be influenced by lack of blinding) uncertain risk of bias (there is insufficient information to assess whether the type of blinding used is likely to induce bias on the outcome measurement) high risk of bias (no blinding or incomplete blinding, and the outcome or the outcome measurement is likely to be influenced by lack of blinding) Incomplete outcome data low risk of bias (the underlying reasons for missing data are unlikely to influence treatment effects or proper methods have been employed to handle missing data) uncertain risk of bias (there is insufficient information to assess whether the missing data mechanism in combination with the method used to handle missing data is likely to induce bias on the outcomes) high risk of bias (the outcomes will likely by biased due to missing data and methods to handle missing data are unsatisfactory) Selective outcome reporting low risk of bias (the trial protocol is available and all of the trial s pre-specified outcomes that are of interest have been reported or similar) 6
7 uncertain risk of bias (there is insufficient information to assess whether the magnitude and direction of the observed effect is related to selective outcome reporting) high risk of bias (not all of the primary outcomes in this review have been reported and not all of the trial s pre-specified outcome that are of interest in the review have been reported) Source of funding low risk of bias (the trial s source(s) of funding did not come from any parties that might have conflicting interest (e.g. the trial was funded by independent organizations) uncertain risk of bias (the source of funding was not clear) high risk of bias (the trial was funded by parties that may have conflicting interests) Trials classified as low risk of bias in sequence generation, allocation concealment, blinding, incomplete data, selective outcome reporting, source of funding and other potentials of bias will be considered as trial with a low risk of bias. Trials with one or more of these mentioned risk of bias domains scored as unclear or high risk of bias will be considered as trial with high risk of bias. To assess all the possible bias components, review manager version 5.2 will be used (19). STATISTICAL METHODS In case of low heterogeneity a meta-analysis will be performed. Random effects meta-analysis will be performed according to the Cochrane Handbook for Systematic Reviews and Interventions (15). The software package Review Manager 5.2 will be used (16).For dichotomous variables, the risk ratio (RR) with 95% confidence interval (CI) will be calculated. For continuous variables, the mean difference (MD) or the standard mean difference (SMD) with 95% CI will be calculated. If applicable, reasons for heterogeneity will be explored. SENSITIVITY ANALYSIS Trials with low risk of bias (all bias components scored as low risk) will be compared to trials with high risk of bias (one or more of bias components scored as unclear or high risk). BIAS EXPLORATION A funnel plot to explore small trial bias and use it s asymmetry in funnel plot of trial size against treatment effect will be performed to asses this bias. Begg s and Egger s tests will be used to test for asymmetry in funnel plots. 7
8 SUBGROUP ANALYSIS Comparing patient groups - Low/moderate risk versus high risk in developing CIN - Cardiac intervention versus other interventions Comparing the different protocols - One limb versus two limbs - Upper extremity versus lower extremity - Number of cycles - Duration of ischemia - Interval between RIPC and contrast administration CONCLUSION The objective is to perform a systematic review using the Cochrane Collaboration-methodology with meta-analyses evaluating the effect of RIPC in preventing of CIN in patients with preexisting kidney disease who had undergo an endovascular intervention with the use of intravascular contrast media. This protocol will be online available prior to the start of the review process at the PROSPERO website. 8
9 REFERENCES 1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2002;39(5): McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. The American journal of medicine. 1997;103(5): McCullough PA. Contrast-induced acute kidney injury. Journal of the American College of Cardiology. 2008;51(15): Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney international. 1995;47(1): Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Journal of the American College of Cardiology. 2004;44(7): Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. Pathophysiology of contrast-induced nephropathy. The American journal of cardiology. 2006;98(6A):14K-20K. 7. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5): Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87(3): Kanoria S, Jalan R, Seifalian AM, Williams R, Davidson BR. Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation. 2007;84(4): Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review. The Journal of surgical research. 2008;150(2): Wever KE, Menting TP, Rovers M, van der Vliet JA, Rongen GA, Masereeuw R, et al. Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. PloS one. 2012;7(2):e Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation. 2012;126(3): Igarashi G, Iino K, Watanabe H, Ito H. Remote ischemic pre-conditioning alleviates contrastinduced acute kidney injury in patients with moderate chronic kidney disease. Circulation journal : official journal of the Japanese Circulation Society. 2013;77(12): Higgins JPT GS. Cochrane Handbook for Systematic Review of Intervention Version [updated 2011]. Available from: www. Cochrane-handbook.org. 9
10 15. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. The American journal of cardiology. 2004;93(12): Toprak O. Conflicting and new risk factors for contrast induced nephropathy. The Journal of urology. 2007;178(6): de Geus HR, Betjes MG, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clinical kidney journal. 2012;5(2): Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 2009;6(7):e Review manager (RevMan) (2008) Version 5.1 for Windows (updated to on September 2010). The Nordic Cochrane Centre, The Cochrane Collaboration Copenhagen. 10
11 ABBREVIATIONS USED IN THIS SYSTEMATIC REVIEW AKI CI CI-AKI CIN KIM-1 L-FABP MD MDRD NGAL RIPC SDM acute kidney injury confidence internal contrast-induced acute kidney injury contrast-induced nephropathy kidney injury molecule-1 liver fatty acid binding protein mean difference mean glomerular filtration rate neutrophil gelatinase-associated lipocalin remote ischemic preconditioning standard mean difference 11
12 Table 1. Risk factors for CIN. Risk factors for CIN Patient-related factors Age > 75 y Pre-existing kidney disease (egfr < 60 ml/min/1.73 m2) Diabetes and impaired glucose tolerance Decreased effective blood volume(heart failure, dehydration) Hypoalbuminemia (< 35 g/l) Anemia Baseline hematocrit value <39% for men and <36% for women Peripheral vascular disease Nephrotoxic medication (e.g. NSAIDs, high-dose diuretic agents) Hyperuricemia Metabolic syndrome Prior stroke Hypertension Renal transplant Procedure-related factors High volume of contrast media Osmolality and ionicity of contrast media Intra-arterial contrast media injection Multiple contrast media exposures in < 72 h Intra-aortic balloon pump y: years; egfr: estimated glomerular filtration rate; CIN: contrast-induced nephropathy; NSAIDs: nonsteroidal anti-inflammatory drugs; h: hours. 12
The Incidence of Contrast Induced Nephropathy in Trauma Patients.
The Incidence of Contrast Induced Nephropathy in Trauma Patients. Item Type Thesis Authors Cordeiro, Samuel Publisher The University of Arizona. Rights Copyright is held by the author. Digital access to
More informationRemote ischemic preconditioning to reduce contrast-induced nephropathy: study protocol for a randomized controlled trial
Sterenborg et al. Trials 2014, 15:119 TRIALS STUDY PROTOCOL Open Access Remote ischemic preconditioning to reduce contrast-induced nephropathy: study protocol for a randomized controlled trial Thomas B
More informationDoreen P. Foley MS RN ANP-C Doctor of Nursing Practice Program Chamberlain College of Nursing
Doreen P. Foley MS RN ANP-C Doctor of Nursing Practice Program Chamberlain College of Nursing This program has been developed solely for the purposes of describing the level of nurse practitioner (NP)
More informationPROTOCOL FORMAT SYSTEMATIC REVIEW ANIMAL INTERVENTION STUDIES
PROTOCOL FORMAT SYSTEMATIC REVIEW ANIMAL INTERVENTION STUDIES Item # Section/topic General 1. Title of the review BY SYRCLE (WWW.SYRCLE.NL) VERSION 0.9 (APRIL 2014) Description Ischemic preconditioning
More informationCorrespondence should be addressed to Lantam Sonhaye;
Radiology Research and Practice Volume 2015, Article ID 805786, 4 pages http://dx.doi.org/10.1155/2015/805786 Research Article Intravenous Contrast Medium Administration for Computed Tomography Scan in
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Drug-eluting balloon angioplasty versus non-stenting balloon angioplasty for peripheral arterial disease of the lower limbs [Cochrane Protocol]
More informationResearch Article Changes in Renal Function in Elderly Patients Following Intravenous Iodinated Contrast Administration: A Retrospective Study
Radiology Research and Practice, Article ID 459583, 4 pages http://dx.doi.org/10.1155/2014/459583 Research Article Changes in Renal Function in Elderly Patients Following Intravenous Iodinated Contrast
More informationAcute Kidney Injury for the General Surgeon
Acute Kidney Injury for the General Surgeon UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011 Epidemiology & Definition Pathophysiology Clinical Studies Management Summary Hobart W. Harris,
More informationDoppler ultrasound, see Ultrasonography. Magnetic resonance imaging (MRI), kidney oxygenation assessment 75
Subject Index Acidemia, cardiorenal syndrome type 3 146 Acute Dialysis Quality Initiative (ADQI) acute kidney injury biomarkers, see Acute kidney injury; specific biomarkers cardiorenal syndrome, see specific
More informationContrast-induced nephropathy
Acute kidney injury with iodinated contrast Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Diagnostic and interventional radiographic procedures in critically ill patients commonly depend on iodinated
More informationMinimizing the Renal Toxicity of Iodinated Contrast
Minimizing the Renal Toxicity of Iodinated Contrast Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Chief Academic and Scientific Officer St. John Providence Health System Detroit, MI USA Outline
More informationContrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
More informationAcute Coronary Syndrome (ACS) Patients with Chronic Kidney Disease being considered for Cardiac Catheterization. PROVINCIAL PROTOCOL March 2015
Acute Coronary Syndrome (ACS) Patients with Chronic Kidney Disease being considered for Cardiac Catheterization PROVINCIAL PROTOCOL March 2015 Contents Introduction.......................1 Assessing kidney
More informationN-acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies
RESEARCH REPORT N-acetylcysteine in the prevention of contrast agent-induced nephrotoxicity in patients undergoing computed tomography studies Hossein Khalili, Simin Dashti-Khavidaki, Hamed Tabifar, Nasrin
More informationControlled Trials. Spyros Kitsiou, PhD
Assessing Risk of Bias in Randomized Controlled Trials Spyros Kitsiou, PhD Assistant Professor Department of Biomedical and Health Information Sciences College of Applied Health Sciences University of
More informationUpdate on Cardiorenal Syndrome: A Clinical Conundrum
Advances in Peritoneal Dialysis, Vol. 27, 2011 Eric J. Chan, 1 Kevin C. Dellsperger 1 3 Update on Cardiorenal Syndrome: A Clinical Conundrum Our understanding of the cardiorenal syndrome continues to progress.
More informationFollow-up of patients with contrast-induced nephropathy
http://www.kidney-international.org & 2006 International Society of Nephrology Follow-up of patients with contrast-induced nephropathy R Solomon 1 and B Barrett 2 1 Fletcher Allen Health Care, University
More informationSAFETY IN THE CATH LAB How to Minimise Contrast Toxicity
SAFETY IN THE CATH LAB How to Minimise Contrast Toxicity Dr. Vijay Kunadian MBBS, MD, MRCP Senior Lecturer and Consultant Interventional Cardiologist Institute of Cellular Medicine, Faculty of Medical
More informationHeart Failure and Cardio-Renal Syndrome 1: Pathophysiology. Biomarkers of Renal Injury and Dysfunction
CRRT 2011 San Diego, CA 22-25 February 2011 Heart Failure and Cardio-Renal Syndrome 1: Pathophysiology Biomarkers of Renal Injury and Dysfunction Dinna Cruz, M.D., M.P.H. Department of Nephrology San Bortolo
More informationRobert M. Jacobson, M.D. Department of Pediatric and Adolescent Medicine Mayo Clinic, Rochester, Minnesota
How to Conduct a Systematic Review: A Workshop 24 th Annual Primary Care Research Methods & Statistics Conference, San Antonio, Texas Saturday, December 3, 2011 Robert M. Jacobson, M.D. Department of Pediatric
More informationTraumatic brain injury
Introduction It is well established that traumatic brain injury increases the risk for a wide range of neuropsychiatric disturbances, however there is little consensus on whether it is a risk factor for
More informationSystematic reviews and meta-analyses of observational studies (MOOSE): Checklist.
Systematic reviews and meta-analyses of observational studies (MOOSE): Checklist. MOOSE Checklist Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease:
More informationNirmal Singh, 1 Justin Z Lee, 2 Jennifer J Huang, 2 See Wei Low, 1 Carol Howe, 3 Anil Pandit, 4 Prakash Suryanarayana, 1 Kwan S Lee 1.
To cite: Singh N, Lee JZ, Huang JJ, et al. Benefit of statin pretreatment in prevention of contrastinduced nephropathy in different adult patient population: systematic review and meta-analysis. Open Heart
More informationEFFECT OF REMOTE ISCHEMIC PRECONDITIONING ON THE INCIDENCE OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS UNDERGOING EVAR (RIP-EVAR STUDY)
EFFECT OF REMOTE ISCHEMIC PRECONDITIONING ON THE INCIDENCE OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS UNDERGOING EVAR (RIP-EVAR STUDY) Diana Gutiérrez Castillo, Enrique M. San Norberto García, Isabel
More informationResults. NeuRA Treatments for internalised stigma December 2017
Introduction Internalised stigma occurs within an individual, such that a person s attitude may reinforce a negative self-perception of mental disorders, resulting in reduced sense of selfworth, anticipation
More informationContrast-Induced Acute Kidney Injury
Journal of the American College of Cardiology Vol. 51, No. 15, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.12.035
More informationThe Incidence Of Contrast-Induced Nephropathy Or Radiocontrast Nephropathy
ISPUB.COM The Internet Journal of Radiology Volume 18 Number 1 The Incidence Of Contrast-Induced Nephropathy Or Radiocontrast Nephropathy K O Kragha Citation K O Kragha. The Incidence Of Contrast-Induced
More informationProblem solving therapy
Introduction People with severe mental illnesses such as schizophrenia may show impairments in problem-solving ability. Remediation interventions such as problem solving skills training can help people
More informationCardiac Catheterization
Cardiac Catheterization Contrast-Induced Acute Kidney Injury and Risk of Adverse Clinical Outcomes After Coronary Angiography A Systematic Review and Meta-Analysis Matthew T. James, MD, PhD; Susan M. Samuel,
More informationLearning from Systematic Review and Meta analysis
Learning from Systematic Review and Meta analysis Efficacy and Safety of Antiscabietic Agents: A Systematic Review and Network Meta analysis of Randomized Controlled Trials KUNLAWAT THADANIPON, MD 4 TH
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/108453
More information16/05/2018 NEFROPATIA DA MEZZO DI CONTRASTO: ANCORA UNA VECCHIA NEMICA?
16/05/2018 NEFROPATIA DA MEZZO DI CONTRASTO: ANCORA UNA VECCHIA NEMICA? Dott. Andrea Boccatonda Università degli Studi G. d Annunzio Chieti Chi di voi non ha mai discusso con un radiologo per eseguire
More informationResults. NeuRA Mindfulness and acceptance therapies August 2018
Introduction involve intentional and non-judgmental focus of one's attention on emotions, thoughts and sensations that are occurring in the present moment. The aim is to open awareness to present experiences,
More information1-year mortality following contrast-induced nephropathy
American Journal of Internal Medicine 2013; 1(1) : 1-6 Published online May 2, 2013 (http://www.sciencepublishinggroup.com/j/ajim) doi: 10.11648/j.ajim.20130101.11 1-year mortality following contrast-induced
More informationClinical research in AKI Timing of initiation of dialysis in AKI
Clinical research in AKI Timing of initiation of dialysis in AKI Josée Bouchard, MD Krescent Workshop December 10 th, 2011 1 Acute kidney injury in ICU 15 25% of critically ill patients experience AKI
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first
More informationsurgery: A systematic review and meta-analysis protocol
Title Perioperative dexmedetomidine and outcomes after adult cardiac surgery: A systematic review and meta-analysis protocol Registration PROSPERO (registered December 8 th, 2015) Authors David McIlroy
More informationCTA in acute stroke assessment
CTA in acute stroke assessment Assumptions: It is more efficient to cancel an unnecessary CTA than to order a CTA after the fact It is more efficient to make 1 trip to the CT scanner Even if no LVO, CTA
More informationPrevention of Contrast-Induced Acute Kidney Injury: Is Simple Oral Hydration Similar To Intravenous? A Systematic Review of the Evidence
Prevention of Contrast-Induced Acute Kidney Injury: Is Simple Oral Hydration Similar To Intravenous? A Systematic Review of the Evidence Swapnil Hiremath 1,2 *, Ayub Akbari 1,2, Wael Shabana 3, Dean A.
More informationENDPOINTS FOR AKI STUDIES
ENDPOINTS FOR AKI STUDIES Raymond Vanholder, University Hospital, Ghent, Belgium SUMMARY! AKI as an endpoint! Endpoints for studies in AKI 2 AKI AS AN ENDPOINT BEFORE RIFLE THE LIST OF DEFINITIONS WAS
More informationARCHE Risk of Bias (ROB) Guidelines
Types of Biases and ROB Domains ARCHE Risk of Bias (ROB) Guidelines Bias Selection Bias Performance Bias Detection Bias Attrition Bias Reporting Bias Other Bias ROB Domain Sequence generation Allocation
More informationResults. NeuRA Hypnosis June 2016
Introduction may be experienced as an altered state of consciousness or as a state of relaxation. There is no agreed framework for administering hypnosis, but the procedure often involves induction (such
More informationA08 Using Kidney Biomarkers for AKI 2: Differential Diagnosis, Interventions and Prognosis
A08 Using Kidney Biomarkers for AKI 2: Differential Diagnosis, Interventions and Prognosis Kent Doi, MD, PhD Emergency and Critical Care Medicine, The Univ of Tokyo, Japan Using kidney biomarkers: Key
More informationPrevention of Contrast induced Nephropathy
55 th Annual Scientific Meeting of The Korean Society of Cardiology 11:50 12:10 Message from Nephrologists Dec 03, 2011 Prevention of Contrast induced Nephropathy Soo Wan Kim, MD, PhD Department of Internal
More informationSupplementary Online Content
Supplementary Online Content Tsai WC, Wu HY, Peng YS, et al. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic
More informationSupplemental Material. Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 1946 to Present
Supplemental Material Supplemental Appendix : Search Strategy Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) 96 to Present. exp Contrast Media/ 907. exp Kidney Diseases/ 8.
More informationJin Wi, 1 Young-Guk Ko, 1 Jung-Sun Kim, 1 Byeong-Keuk Kim, 1 Donghoon Choi, 1 Jong-Won Ha, 1 Myeong-Ki Hong, 1,2 Yangsoo Jang 1,2 ORIGINAL ARTICLE
See Editorial, p 1723 1 Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Republic of Korea 2 Severance Biomedical Science Institute, Yonsei University
More informationZhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou 1,2,3 Author affiliation:
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: AMeta-analysis of Prospective Studies Zhengtao Liu 1,2,3*, Shuping Que 4*, Lin Zhou
More informationThe QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews
The QUOROM Statement: revised recommendations for improving the quality of reports of systematic reviews David Moher 1, Alessandro Liberati 2, Douglas G Altman 3, Jennifer Tetzlaff 1 for the QUOROM Group
More informationASDIN 10th Annual Scientific Meeting Final. COI Disclosure Statement. Intravenous Contrast Media: Basics
COI Disclosure Statement There are no financial relationships or conflicts of interest to disclose with this presentation Melissa Hicks, BA, RT(R)(VI) Vascular Interventional Technologist University of
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Search terms*
Supplementary Figure S1. Search terms* *mh = exploded MeSH: Medical subject heading (Medline medical index term); tw = text word; pt = publication type; the asterisk (*) stands for any character(s) #1:
More informationResults. NeuRA Worldwide incidence April 2016
Introduction The incidence of schizophrenia refers to how many new cases there are per population in a specified time period. It is different from prevalence, which refers to how many existing cases there
More informationThe pathophysiology of contrast medium induced nephropathy
The pathophysiology of contrast medium induced nephropathy Peter Aspelin Professor of Radiology Karolinska Institutet 5th Nordic Course in Emergency Radiology, Oslo 2015 Background Contrast medium-induced
More informationSPRINT: Consequences for CKD patients
SPRINT: Consequences for CKD patients 29 e Workshop Nierziekten Papendal 2018 December 12, 2018 MICHAEL ROCCO, MD, MSCE VARDAMAN M. BUCKALEW JR. PROFESSOR OF MEDICINE PROFESSOR OF PUBLIC HEALTH SCIENCES
More informationEVALUATION OF THE ROLE OF NEPHROTOXIC DRUGS IN CONTRAST INDUCED
EVALUATION OF THE ROLE OF NEPHROTOXIC DRUGS IN CONTRAST INDUCED NEPHROPATHY (CIN) Dr. SIRISHA.A POST GRADUATE KAMINENI INSTITUTE OF MEDICAL SCIENCES NARKETPALLY, TELANGANA INTRODUCTION Contrast-induced
More informationSection 4. CONTRAST INDUCED ACUTE KIDNEY INJURY
Section 4. CONTRAST INDUCED ACUTE KIDNEY INJURY Authors: Martin Gallagher, Vincent D Intini GUIDELINES a. We recommend using either iso-osmolar or low-osmolar iodinated contrast media, rather than high-osmolar
More informationCochrane Pregnancy and Childbirth Group Methodological Guidelines
Cochrane Pregnancy and Childbirth Group Methodological Guidelines [Prepared by Simon Gates: July 2009, updated July 2012] These guidelines are intended to aid quality and consistency across the reviews
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Specific management of IgA nephropathy: role of fish oil
Specific management of IgA nephropathy: role of fish oil Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES Early and prolonged treatment with fish oil may retard
More informationAnimal-assisted therapy
Introduction Animal-assisted interventions use trained animals to help improve physical, mental and social functions in people with schizophrenia. It is a goal-directed intervention in which an animal
More informationJournal Club PowerPoint Template. A Question of Therapy RCT
Journal Club PowerPoint Template A Question of Therapy RCT 1 EBM Process Ask a well built (focused) clinical question Search for the best evidence to answer the question Critically appraise the evidence
More informationUric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George
Uric acid and CKD Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George Hospital @Badves Case Mr J, 52 Male, referred in June 2015 DM type 2 (4 years), HTN, diabetic retinopathy, diabetic
More informationTranscranial Direct-Current Stimulation
Introduction (tdcs) is a non-invasive form of brain stimulation similar to transcranial magnetic stimulation, but instead of using magnets, it uses a lowintensity, constant current applied through scalp
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Closed reduction methods for acute anterior shoulder dislocation [Cochrane Protocol] Kanthan Theivendran, Raj Thakrar, Subodh Deshmukh,
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Protein Restriction to prevent the progression of diabetic nephropathy GUIDELINES
Protein Restriction to prevent the progression of diabetic nephropathy Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES a. A small volume of evidence suggests
More informationSupplementary Online Content
Supplementary Online Content Zarbock A, Schmidt C, Van Aken H, et al; for the RenalRIPC Investigators. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac
More informationOptimal Use of Iodinated Contrast Media In Oncology Patients. Focus on CI-AKI & cancer patient management
Optimal Use of Iodinated Contrast Media In Oncology Patients Focus on CI-AKI & cancer patient management Dr. Saritha Nair Manager-Medical Affairs-India & South Asia GE Healthcare Context Cancer patients
More informationMeta-analyses: analyses:
Meta-analyses: analyses: how do they help, and when can they not? Lee Hooper Senior Lecturer in research synthesis & nutrition l.hooper@uea.ac.uk 01603 591268 Aims Systematic Reviews Discuss the scientific
More informationInfluence of the timing of cardiac catheterization and amount of contrast media on acute renal failure after cardiac surgery
Received: 17.11.2010 Accepted: 10.2.2011 Original Article Influence of the timing of cardiac catheterization and amount of contrast media on acute renal failure after cardiac surgery Mohsen Mirmohammad
More informationResults. NeuRA Forensic settings April 2016
Introduction Prevalence quantifies the proportion of individuals in a population who have a disease during a specific time period. Many studies have reported a high prevalence of various health problems,
More informationEvaluating the Efficacy of Single Daily Dose of 1200mg of N-Acetyl-Cysteine in Preventing Contrast Agent-Associated Nephrotoxicity
ISPUB.COM The Internet Journal of Internal Medicine Volume 6 Number 1 Evaluating the Efficacy of Single Daily Dose of 1200mg of N-Acetyl-Cysteine in Preventing Contrast Agent-Associated Nephrotoxicity
More informationEffect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure
Journal of Cardiology (2010) 56, 300 306 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/jjcc Original article Effect of contrast-induced nephropathy on cardiac outcomes after
More informationMortality Associated With Nephropathy After Radiographic Contrast Exposure
ORIGINAL ARTICLE MORTALITY ASSOCIATED WITH NEPHROPATHY AFTER RADIOGRAPHIC CONTRAST EXPOSURE Mortality Associated With Nephropathy After Radiographic Contrast Exposure AARON M. FROM, MD; BRIAN J. BARTHOLMAI,
More informationContrast-Induced Nephropathy: Evidenced Based Prevention
Contrast-Induced Nephropathy: Evidenced Based Prevention Michael J Cowley, MD, FSCAI Nothing to disclose Contrast-Induced Nephropathy (CIN) Definitions New onset or worsening of renal function after contrast
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Percutaneous access for endovascular aortic aneurysm repair: a systematic review and meta-analysis Shahin Hajibandeh, Shahab Hajibandeh,
More informationDistraction techniques
Introduction are a form of coping skills enhancement, taught during cognitive behavioural therapy. These techniques are used to distract and draw attention away from the auditory symptoms of schizophrenia,
More informationCochrane Breast Cancer Group
Cochrane Breast Cancer Group Version and date: V3.2, September 2013 Intervention Cochrane Protocol checklist for authors This checklist is designed to help you (the authors) complete your Cochrane Protocol.
More informationCATH LAB SYMPOSIUM 2010
CATH LAB SYMPOSIUM 2010 Low resistance system High Pressure in Capillaries to filter plasma RBF: 1.2-1.3 L/min (25% of C.O.) Low AV difference ( shunt ) Kidney: 14 ml O2/L blood Brain: 62 ml O2/L blood
More informationComparison of Three Whole Blood Creatinine Methods for Estimation of Glomerular Filtration Rate Before Radiographic Contrast Administration
Clinical Chemistry / Whole Blood Creatinine for egfr Comparison of Three Whole Blood Creatinine Methods for Estimation of Glomerular Filtration Rate Before Radiographic Contrast Administration Nichole
More informationThe CARI Guidelines Caring for Australasians with Renal Impairment. Membranous nephropathy role of steroids GUIDELINES
Membranous nephropathy role of steroids Date written: July 2005 Final submission: September 2005 Author: Merlin Thomas GUIDELINES There is currently no data to support the use of short-term courses of
More informationIntroduction. Hyuck-Jun Yoon, MD, and Seung-Ho Hur, MD
ORIGINAL ARTICLE DOI 10.4070/kcj.2011.41.5.265 Print ISSN 1738-5520 / On-line ISSN 1738-5555 Copyright 2011 The Korean Society of Cardiology Open Access Determination of Safe Contrast Media Dosage to Estimated
More informationResults. NeuRA Family relationships May 2017
Introduction Familial expressed emotion involving hostility, emotional over-involvement, and critical comments has been associated with increased psychotic relapse in people with schizophrenia, so these
More informationAssessment of estimated GFR and clinical predictors of contrast induced nephropathy among diabetic patients undergoing cardiac catheterization
The Egyptian Heart Journal (2015) 67, 249 258 HOSTED BY Egyptian Society of Cardiology The Egyptian Heart Journal www.elsevier.com/locate/ehj www.sciencedirect.com ORIGINAL ARTICLE Assessment of estimated
More informationof developing contrast -induced
Original Article Singapore Med 1 2009, 50 (3) : 250 Diabetic patients with normal baseline renal function are at increased risk of developing contrast -induced nephropathy post-percutaneous coronary intervention
More informationAcute Kidney Injury in the ED
+ Acute Kidney Injury in the ED + Dr Eric Clark, MD FRCPC University of Ottawa Canada Canadian Association of Emergency Physicians + Outline 1. Diagnostic challenges 2. ED treatment 3. Contrast induced
More informationAmerican Journal of Internal Medicine
American Journal of Internal Medicine 2016; 4(3): 49-59 http://www.sciencepublishinggroup.com/j/ajim doi: 10.11648/j.ajim.20160403.12 ISSN: 2330-4316 (Print); ISSN: 2330-4324 (Online) The Effect of Dose-Reduced
More informationof Contrast Induced Nephropathy
Consensus Guidelines for the Prevention of Contrast Induced Nephropathy Benko A, Fraser-Hill M, Magner P, Capusten B, Barrett B, Myers A, Owen RJ. Correspondence to Canadian Association of Radiologists,
More informationAcute renal failure Definition and detection
Acute renal failure Definition and detection Pierre Delanaye, MD, PhD Nephrology, Dialysis, Transplantation CHU Sart Tilman University of Liège BELGIUM Definition Acute Renal Failure Acute Kidney Injury
More informationSystematic Review & Course outline. Lecture (20%) Class discussion & tutorial (30%)
Systematic Review & Meta-analysisanalysis Ammarin Thakkinstian, Ph.D. Section for Clinical Epidemiology and Biostatistics Faculty of Medicine, Ramathibodi Hospital Tel: 02-201-1269, 02-201-1762 Fax: 02-2011284
More informationComparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
Abstract Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy Morteza Arabmomeni (1), Jamshid Najafian (2), Morteza
More informationGRADE. Grading of Recommendations Assessment, Development and Evaluation. British Association of Dermatologists April 2018
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2018 Previous grading system Level of evidence Strength of recommendation Level of evidence
More informationNeutrophil Gelatinase-Associated Lipocalin as a Biomarker of Acute Kidney Injury in Patients with Morbid Obesity Who Underwent Bariatric Surgery
Published online: October 31, 213 1664 5529/13/31 11$38./ This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial 3. Unported license (CC BY-NC) (www.karger.com/oa-license),
More informationPreventing Nephropathy Induced by Contrast Medium
T h e n e w e ng l a nd j o u r na l of m e dic i n e Preventing Nephropathy Induced by Contrast Medium Brendan J. Barrett, M.B., and Patrick S. Parfrey, M.D. This Journal feature begins with a case vignette
More informationSchool of Dentistry. What is a systematic review?
School of Dentistry What is a systematic review? Screen Shot 2012-12-12 at 09.38.42 Where do I find the best evidence? The Literature Information overload 2 million articles published a year 20,000 biomedical
More informationPROSPERO International prospective register of systematic reviews
PROSPERO International prospective register of systematic reviews Prophylactic cranial irradiation in patients with non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled
More informationBiomarkers of renal diseases. By Dr. Gouse Mohiddin Shaik
By Dr. Gouse Mohiddin Shaik Introduction Renal system performs several functions Excretory Waste products like urea, creatinine, drug, toxins clearance Regulatory Water, electrolyte and acid base balance
More informationDeterminants of quality: Factors that lower or increase the quality of evidence
Determinants of quality: Factors that lower or increase the quality of evidence GRADE Workshop CBO, NHG and Dutch Cochrane Centre CBO, April 17th, 2013 Outline The GRADE approach: step by step Factors
More informationCardiac Catheterization
Cardiac Catheterization Contrast-Induced Acute Kidney Injury and Risk of Adverse Clinical Outcomes After Coronary Angiography A Systematic Review and Meta-Analysis Matthew T. James, MD, PhD; Susan M. Samuel,
More informationMethod. NeuRA Biofeedback May 2016
Introduction is a technique in which information about the person s body is fed back to the person so that they may be trained to alter the body s conditions. Physical therapists use biofeedback to help
More information